Volume 155, Issue 1, 8 August 2014, Pages 80–103
Review
Lawsonia inermis L. (henna): Ethnobotanical, phytochemical and pharmacological aspects
Abstract
Ethnopharmacological relevance
The use of Lawsonia inermis
L. (henna) for medicinal and cosmetic purposes is inextricably linked
to ancient and modern cultures of North Africa and Asia. Literature and
artwork indicates that Lawsonia inermis played an important
holistic role in the daily lives of some ancient cultures, providing
psychological and medicinal benefits, as well as being used for personal
adornment. Although henna was historically applied to the hands and
feet to protect against fungal pathogens and to hair to combat lice and
dandruff, other traditional uses include the treatment of liver and
digestive disorders, reduction of tissue loss in leprosy, diabetic foot
disorders and ulcers.
Phytochemistry: Almost
70 phenolic compounds have been isolated from various parts of the
plant. Naphthaquinones, which include the dyeing principle lawsone, have
been linked to many of the pharmacological activities. The terpene,
β-ionone is largely responsible for the pungent odour of the essential
oil isolated from the flowers. In addition to other volatile terpenes,
some non-volatile terpenoids, a single sterol, two alkaloids and two
dioxin derivatives have also been isolated from the plant.
Bioactivity: Henna is a pharmacologically important plant with significant in vitro and in vivo
biological activities. Although a myriad of pharmacological activities
have been documented, the antioxidant and antimicrobial activities are
the most thoroughly investigated. Some incidents of adverse reactions
following application to the skin have been reported, but these are
mainly confined to cases involving individuals with glucose-6-phosphate
dehydrogenase deficiency and reactions to adulterants added to henna
products.
Conclusions: Adulteration of henna
is very common and may have resulted in unwarranted scientific findings.
Phytochemical profiling studies of the plant, which are crucial for the
establishment of proper quality control protocols, are lacking and
hamper the development of medicinal products. Although many in vitro studies have been conducted to evaluate the pharmacological activities and many in vivo studies have focussed on the toxicity of extracts, more in vivo
studies to validate pharmacological activities are needed. The roles of
specific compounds and their synergies have not been comprehensively
investigated.
Abbreviations
- ABTS, [2,2′-azino-bis(3-ethyl benzthiazoline-6-sulfonic acid)];
- BHT, Butylated hydroxy toluene;
- b.w., Body weight;
- CNS, Central nervous system;
- DMBA, 7,12-dimethylbenz(a)anthracene;
- DPPH, 1,1-diphenyl-2-picryl hydrazyl;
- EC, effective concentration;
- FTC, Ferric thiocyanate;
- G6PD, Glucose-6-phosphate dehydrogenase;
- IC50, Half maximal inhibitory concentration;
- IZD, Inhibition zone diameter;
- LDH, Lactose dehydrogenase;
- MBC, Minimum bacterial count;
- MIC, Minimum inhibitory concentration;
- p.o., Per os;
- PPD, Paraphenylenediamine;
- RBC, Red blood cell;
- SGOT, Serum glutamate oxaloacetate transaminase;
- SGPT, Serum glutamate pyruvate transaminase;
- TBA, Thiobarbituric acid;
- WBC, White blood cell
Keywords
- Henna;
- Lawsone;
- Antioxidant;
- Antimicrobial;
- Contact dermatitis;
- Paraphenylenediamine
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.